Ayurvedic medicine for hair loss is a topic of growing interest in the UK, with many people turning to traditional herbal remedies such as bhringraj, amla, and ashwagandha as alternatives or complements to conventional treatments. Rooted in a 3,000-year-old Indian healing tradition, Ayurveda approaches hair loss holistically, considering diet, stress, and scalp health. However, the clinical evidence supporting these remedies remains limited, and no Ayurvedic product is currently licensed by the MHRA for treating hair loss. This article explores what Ayurvedic medicine offers, what the evidence shows, key safety considerations, and when to seek NHS care.

What Is Ayurvedic Medicine and How Is It Used for Hair Loss?

Ayurvedic medicine is a 3,000-year-old Indian healing tradition that attributes hair loss to excess Pitta dosha; these concepts are not validated by UK biomedical evidence or recognised within NHS clinical practice.

Not sure if this is normal? Chat with one of our pharmacists →

Ayurvedic medicine is a traditional system of healing that originated in India over 3,000 years ago. The word 'Ayurveda' derives from the Sanskrit terms for 'life' (ayur) and 'knowledge' (veda). It is based on the traditional principle that health depends on a balance between three biological energies, or doshas — Vata, Pitta, and Kapha — and that illness arises when this balance is disrupted. In Ayurvedic philosophy, hair loss is often attributed to an excess of Pitta dosha, which is associated with heat and inflammation. It is important to understand that these are traditional cultural concepts and are not validated by UK biomedical evidence or recognised within NHS clinical practice.

Practitioners of Ayurveda approach hair loss holistically, considering diet, lifestyle, stress levels, and digestive health alongside topical treatments. Interventions may include herbal oils massaged into the scalp, oral herbal supplements, dietary modifications, and practices such as yoga and meditation.

In the UK, interest in Ayurvedic medicine has grown considerably, with a range of products available in health food shops, pharmacies, and online retailers. Ayurvedic medicine is not regulated in the same way as conventional medicine in the UK, and practitioners are not required to hold statutory registration. Where voluntary registers exist, you can check whether a practitioner is listed on a register accredited by the Professional Standards Authority (PSA). Individuals considering Ayurvedic treatments should discuss their use with a GP or pharmacist before starting, particularly if they are pregnant, breastfeeding, giving products to children, or have liver or kidney disease.

It is also worth understanding the distinction between different types of products. Herbal medicines making medicinal claims must hold either a Traditional Herbal Registration (THR) or a full marketing authorisation from the MHRA. Many Ayurvedic products sold in the UK are marketed as food supplements, which are not assessed for efficacy or, in many cases, for safety by a regulatory body before sale.

Common Ayurvedic Remedies Promoted for Hair Loss in the UK

Commonly promoted remedies include bhringraj, amla, ashwagandha, brahmi, neem, and fenugreek, but all benefit claims reflect traditional use or early preclinical findings only, with no robust human clinical trial evidence supporting any of them.

A number of Ayurvedic herbs and formulations are widely promoted for hair loss, both as topical applications and oral supplements. The following are among the most commonly encountered. All benefit claims listed below reflect traditional use or early preclinical findings only; none are supported by robust human clinical trial evidence, and no Ayurvedic herbal product is authorised by the MHRA or EMA for treating hair loss.

• Bhringraj (Eclipta alba): Often referred to in Ayurvedic tradition as the 'king of herbs' for hair, bhringraj oil is applied to the scalp. Some animal studies have suggested possible effects on the hair follicle cycle, but human evidence is lacking.

• Amla (Indian gooseberry, Phyllanthus emblica): Rich in vitamin C and antioxidants, amla is used in oils, powders, and supplements. Laboratory studies have demonstrated antioxidant activity, though this has not been shown to translate to clinical benefit for hair loss in humans.

• Ashwagandha (Withania somnifera): An adaptogenic herb used orally, ashwagandha is promoted for reducing stress-related hair loss. Some trials suggest it may reduce perceived stress, though direct evidence linking it to hair regrowth is absent. Safety note: Rare cases of liver injury (hepatotoxicity) have been reported in association with ashwagandha supplements. It may also interact with thyroid medications and immunosuppressants. Avoid use in pregnancy.

• Brahmi (Bacopa monnieri): Applied as an oil or taken orally, brahmi is traditionally said to support scalp health. Human evidence is very limited.

• Neem (Azadirachta indica): Used for its purported antimicrobial and anti-inflammatory properties as a topical scalp application. Safety note: Neem should be avoided in pregnancy and is not recommended for use in young children.

• Fenugreek (Trigonella foenum-graecum): Seeds are used as a paste or taken as a supplement. Safety note: Fenugreek may increase bleeding risk and can lower blood glucose; caution is advised in people taking anticoagulants or antidiabetic medicines.

These remedies are frequently marketed as natural alternatives to pharmaceutical treatments. However, 'natural' does not automatically mean safe or effective, and the quality and composition of commercially available products can vary considerably between batches and manufacturers. When purchasing herbal products, look for those bearing a THR registration number on the packaging, a full list of ingredients with strengths, a batch or lot number, and a UK responsible person's contact address. Be particularly cautious when buying products online from outside the UK.

What Does the Clinical Evidence Say?

Clinical evidence for Ayurvedic remedies in hair loss is limited, with most studies small-scale, preclinical, or methodologically weak; NICE and NHS guidance do not recommend these treatments as evidence-based interventions.

The clinical evidence base for Ayurvedic remedies in the treatment of hair loss remains limited and, in many cases, preliminary. Most studies conducted to date are small in scale, lack robust controls, or have been carried out in laboratory or animal settings rather than in well-designed human clinical trials. No Ayurvedic herbal product is currently licensed or authorised by the MHRA or the European Medicines Agency (EMA) for the treatment of any form of hair loss. As such, it is not currently possible to draw firm conclusions about the efficacy of these treatments for conditions such as androgenetic alopecia (male or female pattern hair loss), alopecia areata, or telogen effluvium.

Some individual ingredients have shown modest signals in early research. For example, a small number of studies suggest that bhringraj extract may have hair growth-promoting properties in animal models, potentially by influencing the hair follicle cycle. Amla has demonstrated antioxidant activity in laboratory studies, though this has not been shown to produce clinical benefit in humans. Ashwagandha has been investigated for its adaptogenic effects on cortisol, and some trials suggest it may reduce perceived stress — a known contributor to telogen effluvium — though direct evidence linking it to hair regrowth is lacking.

Publication bias and methodological inconsistencies make it difficult to evaluate the existing literature objectively. The majority of studies have not been conducted to the standards required by regulatory bodies such as the MHRA or EMA. NICE clinical knowledge summaries and NHS guidance do not recommend Ayurvedic treatments as evidence-based interventions for hair loss. Until larger, well-controlled randomised trials are published, healthcare professionals are unable to endorse these treatments for hair loss. Patients should be encouraged to discuss any supplements they are taking with their GP or pharmacist.

Safety Concerns and MHRA Guidance on Ayurvedic Products

The MHRA has issued safety alerts regarding heavy metal contamination in some Ayurvedic preparations, and additional risks include herb-drug interactions, hepatotoxicity, and adulteration with undisclosed pharmaceutical ingredients.

Worried about interactions with other medications? Speak to one of our pharmacists →

Safety is a significant consideration when using Ayurvedic products, and the MHRA has issued guidance and safety alerts on this topic on several occasions. A key concern is the potential for heavy metal contamination in some Ayurvedic preparations. Certain traditional formulations intentionally incorporate metals such as lead, mercury, and arsenic — a practice known as rasa shastra — which are processed in ways believed within the tradition to render them therapeutic. However, these products carry a genuine risk of heavy metal toxicity and have been associated with cases of poisoning reported in the UK and internationally. The MHRA has issued specific alerts regarding contaminated Ayurvedic medicines.

Additional safety concerns include:

• Herb-drug interactions: Ayurvedic herbs can interact with prescribed medications. For example, ashwagandha may affect thyroid function tests and potentiate thyroid medications or immunosuppressants; fenugreek may increase bleeding risk in people taking anticoagulants and can lower blood glucose in those on antidiabetic drugs; neem may also affect blood glucose levels.

• Hepatotoxicity: Rare cases of liver injury have been reported with certain herbal supplements, including ashwagandha. Seek medical advice promptly if you develop symptoms such as jaundice, dark urine, or abdominal pain after starting any herbal product.

• Adulteration: Some products sold online or in unregulated markets have been found to contain undisclosed pharmaceutical ingredients or contaminants.

• Lack of standardisation: The concentration of active compounds in herbal products can vary significantly between batches and manufacturers.

• Bespoke unlicensed remedies: Under the herbal practitioner exemption in UK law, a registered herbal practitioner may prepare an unlicensed remedy for an individual patient following a one-to-one consultation. If you receive such a product, ask for full ingredient labelling and discuss it with your GP or pharmacist.

Under UK law, herbal medicines sold to the public must either hold a Traditional Herbal Registration (THR) — indicated by the THR logo and a nine-digit registration number on packaging — or a full marketing authorisation. THR status indicates that a product meets standards of quality and safety for traditional use; it does not confirm efficacy. The MHRA advises consumers to purchase only registered products and to be cautious of products bought online from outside the UK.

Ayurvedic products should be avoided in pregnancy, during breastfeeding, and in children unless specifically advised by a clinician. People with liver or kidney disease should seek medical advice before use.

If you experience any suspected adverse effects after taking an Ayurvedic or other herbal product, report this via the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk and seek medical advice promptly.

NHS-Recommended Treatments for Hair Loss

NHS-recommended treatments for androgenetic alopecia include licensed topical minoxidil for men and women, and prescription-only finasteride for men; alopecia areata may be treated with potent topical corticosteroids or, in severe cases, JAK inhibitors under specialist supervision.

The NHS recognises several evidence-based treatments for hair loss, and the appropriate option depends on the underlying cause and type of alopecia. It is important to establish a diagnosis before beginning any treatment, as hair loss can result from a wide range of conditions including androgenetic alopecia, alopecia areata, thyroid disorders, nutritional deficiencies, and scalp infections.

For androgenetic alopecia (the most common form), the following treatments have the strongest evidence base:

• Topical minoxidil: Available over the counter as a solution or foam, topical minoxidil is licensed in the UK for both men and women. It works by prolonging the anagen (growth) phase of the hair cycle and increasing follicular size. Results typically take three to six months to become apparent, and treatment must be continued to maintain benefit.

• Oral minoxidil: It is important to note that oral minoxidil is not licensed in the UK for hair loss (it is licensed for hypertension). Its use for alopecia is off-label and should only be initiated and monitored by a specialist. Potential side effects include low blood pressure, fluid retention, rapid heart rate, and unwanted body hair growth (hypertrichosis). Patients should be counselled about these risks before starting.

• Finasteride (1 mg): A prescription-only oral medication for men, finasteride inhibits the enzyme 5-alpha reductase, reducing conversion of testosterone to dihydrotestosterone (DHT), which is implicated in follicular miniaturisation. In the UK, finasteride for hair loss is generally available via private prescription rather than NHS prescription. It is contraindicated in pregnancy and in women of childbearing potential due to the risk of feminisation of a male foetus. Women who are or may become pregnant should not handle crushed or broken finasteride tablets. Men should be counselled about potential sexual side effects before starting.

For alopecia areata, NICE guidance supports the use of potent topical corticosteroids as a first-line treatment in primary care, with referral to a dermatologist for more extensive or treatment-resistant cases. Intralesional corticosteroid injections and immunotherapy may be considered in specialist settings. For severe alopecia areata, NICE has approved certain JAK inhibitors — including baricitinib and ritlecitinib — subject to local commissioning decisions. These treatments are initiated and monitored by dermatologists and are not suitable for all patients; eligibility criteria apply.

Regarding investigations, NICE CKS guidance recommends considering a full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH) as first-line tests in most presentations of hair loss. Testing for vitamin D, zinc, or other micronutrients should be guided by clinical judgement and individual risk factors, rather than performed routinely.

Nutritional deficiencies — particularly iron deficiency (assessed via ferritin) — should be investigated and corrected where identified, as these can contribute to diffuse hair shedding.

Non-pharmacological options, including scalp camouflage products and wigs (which may be available on NHS prescription in some circumstances), can also be discussed with a GP or dermatologist.

The NHS does not currently recommend Ayurvedic treatments as part of standard care pathways for hair loss.

When to See a GP About Hair Loss

You should see a GP if you experience sudden patchy hair loss, diffuse shedding lasting more than two to three months, scalp inflammation, or hair loss accompanied by systemic symptoms such as fatigue or weight changes.

Hair loss is a common concern, but certain patterns and associated symptoms warrant prompt medical assessment. Many people delay seeking help, either attributing hair loss to stress or ageing, or attempting self-treatment with over-the-counter or complementary remedies. While this is understandable, early diagnosis can make a meaningful difference to treatment outcomes.

You should consider making an appointment with your GP if you notice any of the following:

• Sudden or rapid hair loss, particularly if occurring in patches (which may suggest alopecia areata)

• Diffuse shedding that has persisted for more than two to three months

• Scalp symptoms such as redness, scaling, itching, or pain, which may indicate a dermatological condition such as scalp psoriasis or tinea capitis (ringworm of the scalp) — the latter is particularly important to identify and treat promptly, especially in children

• Signs that may suggest scarring alopecia, including a painful or inflamed scalp, pustules, loss of visible follicular openings, or progressive scarring — these warrant urgent dermatology referral, as scarring alopecia can cause permanent hair loss if not treated early

• Hair loss accompanied by other symptoms, such as fatigue, weight changes, or irregular periods, which could point to an underlying systemic condition such as hypothyroidism or polycystic ovary syndrome (PCOS)

• Hair loss in children, which always warrants medical evaluation

• Concerns about a product you are taking, including Ayurvedic supplements — particularly if you develop new symptoms such as jaundice, abdominal pain, or dark urine after starting them

Your GP can arrange relevant blood tests, assess the pattern and extent of hair loss, and refer you to a dermatologist if needed. If you have a rapidly progressing or inflamed scalp condition, avoid starting new systemic treatments until you have been assessed. It is also important to inform your GP of any herbal or complementary products you are using, as these may interact with prescribed treatments or affect test results. Open communication with your healthcare team ensures that you receive safe, personalised, and evidence-based care.

Frequently Asked Questions